Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 8,075 | 7,829 | 9,430 | 9,998 | 10,190 |
| Operating Income | -8,075 | -7,829 | -9,430 | -9,998 | -10,190 |
| Other Income | 138 | 74 | -22 | -253 | 521 |
| Pre-tax Income | -7,937 | -7,755 | -9,452 | -10,251 | -9,669 |
| Net Income Continuous | -7,937 | -7,755 | -9,452 | -10,251 | -9,669 |
| Net Income | $-7,937 | $-7,755 | $-9,452 | $-10,251 | $-9,669 |
| EPS Basic Total Ops | -7.25 | -7.08 | -9.00 | -9.60 | -9.20 |
| EPS Basic Continuous Ops | -7.25 | -7.18 | -8.90 | -9.68 | -9.13 |
| EPS Diluted Total Ops | -7.25 | -7.08 | -9.00 | -9.60 | -9.20 |
| EPS Diluted Continuous Ops | -7.25 | -7.18 | -8.90 | -9.68 | -9.13 |
| EBITDA(a) | $-8,011 | $-7,763 | $-9,361 | $-9,937 | $-10,114 |